Ispire Technology Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISPR research report →
Range $2.9 – $2.9
Price Chart
About the company
Ispire Technology Inc. is a company that specializes in the production of electronic cigarettes and cannabis-related vaping devices. Established in 2019, its primary operational base is located in Los Angeles, California.
- CEO
- Tuanfang Liu
- IPO
- 2023
- Employees
- 88
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on ISPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $71.05M
- P/E
- -2.42
- Fwd P/E
- 61.50
- PEG
- -4.59
- P/S
- 0.96
- P/B
- -2.57
- EV/EBITDA
- -2.40
- Div Yield
- 0.00%
- Gross Margin
- 12.45%
- Op Margin
- -38.67%
- Net Margin
- -39.04%
- ROE
- 165.45%
- ROIC
- -171.23%
Latest fiscal year · YoY change
- Revenue
- $96.01M-24.7%
- Gross Profit
- $12.30M-45.7%
- Op Income
- $-32,592,524
- Net Income
- $-33,204,044+15.4%
- EPS
- $-0.58+15.9%
- OCF Growth
- -7621.9%
- FCF Growth
- -10229.1%
- 52W High
- $3.87
- 52W Low
- $1.01
- 50D MA
- $1.42
- 200D MA
- $1.71
- Beta
- 2.02
- RSI (14)
- 41
- Avg Volume
- 20.34K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ispire posted a sequentially better first quarter with revenue up, gross margin rebounding, and adjusted EBITDA slightly positive, while management highlighted Malaysia, nicotine pouches, and IKE as growth drivers.· November 9, 2026
- Revenue was $27.5 million, down 9.3% year over year but up 3.2% sequentially from Q4 FY2026.
- Gross profit was $4.5 million and gross margin was 16.2%, up from 6.3% in the prior quarter after Q4 inventory-related pressure.
- Adjusted EBITDA turned slightly positive at $136,000, improving by $2.4 million sequentially.
- Net loss was $6.4 million, or $0.11 per share, versus a $3.3 million loss a year ago and $13.8 million in Q4.
- Management said AR cleanup is nearing completion, with net accounts receivable at $13.5 million and no further write-downs or major credit-loss accounting planned after FY2027.
Ispire reported first-quarter FY2027 revenue of $27.5 million, versus $30.4 million in Q1 FY2026 and $26.7 million in Q4 FY2026; gross profit was $4.5 million and gross margin was 16.2%, versus $5.1 million and 17.0% a year ago, while sequential gross margin improved from 6.3%. Net loss was $6.4 million, or $0.11 per share, compared with a $3.3 million loss, or $0.06 per share, in the prior-year quarter; adjusted EBITDA was a positive $136,000 versus a $2.3 million loss in Q4. Cash and cash equivalents were $15.6 million at quarter end, total debt was $0.5 million, and net cash used in operating activities was $1.6 million. Management said Q1 revenue was pressured by weaker European demand tied to restrictive vaping regulation, while gross margin recovered from the prior quarter’s inventory impairment. Looking ahead, management did not provide formal numeric guidance, but said it expects Malaysia, vapor ODM, nicotine pouches, and IKE to drive fiscal 2027 growth and improve economics.
Steven Przybyla framed the quarter as further evidence of the company’s turnaround, emphasizing sequential revenue growth, improved gross margin, a lower cost base, and reduced receivables. He said Malaysia is becoming a key near-term catalyst, both because of capacity and because it offers a tariff and supply-chain advantage versus China, and he highlighted the expected end of China’s export VAT rebate as a possible additional tailwind. His tone was optimistic and strategic, with repeated emphasis on converting pipeline opportunities into commercial results.
Jie Yu focused on the financial cleanup and operating leverage story. He quantified the quarter’s 16.2% gross margin, the $10.6 million of total operating expenses, and noted that excluding credit loss, operating expenses were $5.9 million, down 3.7% from $6.1 million a year ago and slightly below Q4’s level. She also cited $4.8 million of credit loss expense, $15.6 million of cash, $0.5 million of debt, $0.4 million of working capital, and $1.8 million of investing cash outflow, mainly tied to the IKE joint venture and intangible assets.
Analysts pressed management on whether Malaysia needs to be cheaper than Shenzhen or if customers will pay more for a Malaysian footprint; management replied that customers care about price, but also about stability, regulatory certainty, and IP protection, and said quoted Malaysian orders are already very close to China pricing. On regulation, management said the midterm results should not materially change FDA/CTP behavior and expects continued support for reduced-risk products. Management also said growth over the next several years should come from Southeast Asia and South America, led by regional brand expansion rather than only the large tobacco majors.
The call showed tangible sequential improvement: revenue, margin, adjusted EBITDA, and net loss all moved in the right direction after a difficult Q4. Management also pointed to multiple growth vectors—Malaysia manufacturing, a likely Southeast Asian OEM/ODM deal, nicotine pouches through Jincheng, and IKE 2.0—suggesting the company has several shots at reaccelerating sales.
Revenue is still below last year’s level, and Europe remains a drag because of restrictive vaping regulations, disposable bans, and excise-tax changes that are slowing distributor orders. The company also remains in cleanup mode: credit loss expense was still high, operating cash flow was negative, and management acknowledged more work is needed on receivables and cash flow even as it improves the business.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 34.7%
- Shares Outstanding
- 57.77M
- Float Shares
- 20.05M
of shares held by institutions
50 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Yong Rong (Hk) Asset Management Ltd | 1.50M | 0 |
| Potomac Capital Management, Inc. | 598.67K | ▲ 70 |
| Vanguard Group Inc | 433.40K | ▲ 11.88K |
| Blackrock, Inc. | 344.20K | ▼ 65.41K |
| Geode Capital Management, LLC | 273.22K | ▲ 12.73K |
| Millennium Management LLC | 240.20K | ▼ 19.84K |
| Vanguard Capital Management LLC | 202.80K | ▲ 5.08K |
| Vanguard Fiduciary Trust Co | 101.03K | 0 |
| Susquehanna International Group, Llp | 74.55K | ▼ 18.90K |
| Goldman Sachs Group Inc | 71.68K | ▼ 71.87K |
| State Street Corp | 64.47K | 0 |
| Independent Advisor Alliance | 50.09K | ▲ 30.09K |
Held by 12 ETFs
Biggest fund positions in ISPR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 14, 26 | Burch Christopher Robert | other | 45,760 |
| Aug 14, 26 | Cox Brent | other | 53,555 |
| Aug 14, 26 | Fargis John | other | 45,760 |
| Mar 19, 26 | Fargis John | other | 35,526 |
| Mar 19, 26 | Cox Brent | other | 35,526 |
| Mar 19, 26 | Burch Christopher Robert | other | 35,526 |
| Mar 2, 26 | Wang Michael Xue | buy | 1,737 |
| Mar 2, 26 | Wang Michael Xue | buy | 1,163 |
| Mar 2, 26 | Wang Michael Xue | buy | 100 |
| Feb 27, 26 | Wang Michael Xue | buy | 916 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ISPR coverage
Recent articles, reports, and earnings notes.
No research on ISPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ISPR report →Ispire Technology Inc. (ISPR) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 9
What Ispire Technology (ISPR) Said on Its Q1 Earnings Call
marketbeat.com · Nov 9
Ispire Technology (NASDAQ:ISPR) Shares Down 3.4% – Here’s What Happened
defenseworld.net · Oct 15
IKE Tech Launches IKE 2.0 to Bring Continuous Compliance to Regulated Products
prnewswire.com · Sep 28
Ispire Technology Inc. (ISPR) Q4 2026 Earnings Call Transcript
seekingalpha.com · Sep 16
Ispire Technology Q4 Earnings Call Highlights
marketbeat.com · Sep 16
Ispire Technology Inc. Reports Fourth Quarter and Fiscal Year 2026 Financial Results
accessnewswire.com · Sep 16
Ispire Technology Inc. (ISPR) Reports Q4 Loss, Tops Revenue Estimates
zacks.com · Sep 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.